GenesisCare to launch $245 million term loan B on Tuesday morning

By Sara Rosenberg

New York, June 14 - GenesisCare is set to hold a bank meeting at 10:30 a.m. ET in New York on Tuesday to launch a $245 million seven-year term loan B, according to a market source.

UBS Securities LLC is the lead bank on the deal.

The term B has 101 soft call protection for six months and amortization of 1% per annum, the source said.

In addition to the B loan, the company is getting a A$30 million revolver, the source continued.

Proceeds will be used to refinance existing debt and fund a dividend payment.

GenesisCare is a Sydney, Australia-based provider of cardiology, radiation oncology and sleep treatments.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.